Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
about
Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitisIsolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidasesLEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interactionHuman tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patientsSkin barrier defects in atopic dermatitisDefining the extended substrate specificity of kallikrein 1-related peptidases.Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitorKallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.Culture, immortalization, and characterization of human meibomian gland epithelial cells.Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum.Protease activity, localization and inhibition in the human hair follicle.A pilot study of emollient therapy for the primary prevention of atopic dermatitisInhibition of transcription factor specificity protein 1 alters the gene expression profile of keratinocytes leading to upregulation of kallikrein-related peptidases and thymic stromal lymphopoietin.Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment.Protease-Activated Receptor-2 Is Associated with Terminal Differentiation of Epidermis and Eccrine Sweat Glands.The kallikrein world: an update on the human tissue kallikreins.Cellular distribution of human tissue kallikreins: immunohistochemical localization.T Helper 1 and T Helper 2 Cytokines Differentially Modulate Expression of Filaggrin and its Processing Proteases in Human KeratinocytesNew insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Stratum corneum proteases and dry skin conditions.Unleashing the therapeutic potential of human kallikrein-related serine proteases.Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis.Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays.Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas.Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids.Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes.Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).Expression and regulation of murine SPINK12, a potential orthologue of human LEKTI2.The serine protease marapsin is expressed in stratified squamous epithelia and is up-regulated in the hyperproliferative epidermis of psoriasis and regenerating wounds.Transition to an Aquatic Habitat Permitted the Repeated Loss of the Pleiotropic KLK8 Gene in Mammals.Profiling of serine protease activities in human stratum corneum and detection of a stratum corneum tryptase-like enzyme.Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod.Influence of Aqueous Cream BP on corneocyte size, maturity, skin protease activity, protein content and transepidermal water loss.Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.The serine protease inhibitor of Kazal-type 9 (SPINK9) is expressed in lichen simplex chronicus, actinic keratosis and squamous cell carcinoma.Expression of bleomycin hydrolase in keratinization disorders.Adaptive Evolution Favoring KLK4 Downregulation in East Asians.Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy
P2860
Q24632061-F4137826-D172-45BA-B415-78BDEC40D980Q24633536-4A5F8106-8B8D-4AFA-A655-32E969BB6A86Q24675839-8A93C1D4-2358-4799-9A05-75DF4A182BE4Q28303447-3B9F3C82-E8F6-46D6-BB04-9F796001D7F4Q30405464-FC5A2CAF-F06F-42A2-BD4C-4458FC4F4F81Q33304675-C386FCCD-840E-4D8A-8435-FF8251DD32F4Q33405253-AAEFCDE9-0CCF-4A22-8CA1-852C61E68B85Q33715944-F3A571AD-C7C3-4C0F-A3E9-64F0E48A5292Q34022565-D37F92A5-F464-4AAD-8CF4-C8BBAE1A6721Q34541923-362138C7-C8F1-498B-9573-A6D98455BA89Q34693322-B04321D4-1D32-47A7-9E8B-B239162EF56DQ35166369-87CF14B4-7165-4E4C-B03D-7A6733BBBEB3Q35349913-7CD56D53-6C74-46E9-9CA0-DDDF275583CEQ35350228-2C93B760-6CC5-4C43-84D3-06E96F727DA3Q35931878-F9A4163A-3C82-4DD1-805B-BE5DB3C42622Q36519354-C54443D3-BCA2-489F-A082-D6533E90D827Q36519359-0B2BF5F0-E75B-4784-847B-AA233A1A4947Q36705578-F0F02D0E-E420-493E-9B33-01250446DF18Q37453804-4EBE4D3E-31F8-4F61-A41B-8C60FE63DAE8Q37952006-305229D5-0409-4C7C-993F-542A67308D40Q38050991-84E96724-AD25-474A-ABC3-C72A1F79FA32Q38362486-EAF84E78-7530-460C-97A4-DF7EB1CC7A98Q38677842-219AC4CF-2DD2-442F-8D2A-8429F3ABF753Q38760061-3BBD9F47-0F90-445E-BFB1-BF07EA05D955Q39637184-19898976-56E1-42D8-9859-2B0CD4B69D51Q41466936-683B32D0-9A67-4C8B-9913-C78175F75BA4Q41854925-7080A8D7-E1F6-4037-8671-BD9636BB9C74Q41950008-18A20508-B3A4-423C-9D1C-93A724623E4CQ43418010-9571F0EA-20A0-421E-960B-7EBFED5455BAQ44584244-A0BF2497-74E2-4AEB-A668-D8E90A24BDB2Q46140598-22471F42-B18A-4AEF-818B-D0BE5380C0CDQ46260201-E8CE2E84-CC5C-4CCD-BA3D-D8F17C56049FQ46588345-B424E3AC-3F4B-4B89-80D6-B3109C0AB490Q46943368-E5DCCFAD-49CB-4D55-9B51-B1FC6A8468F4Q47384355-7DFF5021-483E-4505-B27B-0CF51DF8EE53Q51626598-772DF762-625A-4CA3-B943-CC43D144E9C6Q53215851-CF328EE6-C764-46B0-A075-8AEE0AD76D13Q53769382-28EA67AF-85E4-4498-AB4D-64874EADD376Q53787874-B5B69146-1DE9-4D33-AA6A-6BFE89862712Q57941543-C1DE399A-3BAD-45D8-9708-E725AEC59BB3
P2860
Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
@en
Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
@nl
type
label
Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
@en
Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
@nl
prefLabel
Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
@en
Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
@nl
P2093
P2860
P1476
Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
@en
P2093
Takehara K
P2860
P304
P356
10.1111/J.1365-2133.2005.06754.X
P407
P577
2005-08-01T00:00:00Z